Clinical trials
Alopecia clinical trials
Below are recruiting alopecia clinical trials, each written for real people, not researchers. We’re tracking 82 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07381556RecruitingPhase 4
Comparing cyclosporine and methotrexate for kids with alopecia areata
This study compares two medicines, cyclosporine and methotrexate, to see which works better for children with alopecia areata (a condition causing hair loss). It aims to help doctors choose the best treatment for each child.
RotterdamAges 2–17 - NCT06283316Recruiting
A registry for alopecia areata treatments
This trial is a registry that collects information from people with alopecia areata who are starting or using body-wide treatments. It helps doctors learn more about how these treatments work in real life.
RotterdamAges 16 years+ - NCT07733063Recruiting
Blood markers for ferroptosis in Alopecia Areata
This study looks at certain blood markers (GPX4 and MDA) related to a process called ferroptosis in people with Alopecia Areata. The goal is to better understand this condition and possibly find new treatment targets.
Istanbul, Cerrahpasa MahallesiAges 18–65 - NCT07499713Enrolling by invitation
Blood proteins and nail blood vessels in alopecia areata
This study looks at whether certain proteins in your blood (VEGF-A and VCAM-1) are linked to changes in the tiny blood vessels at the base of your fingernails in people with alopecia areata. It may help doctors understand more about the condition and how it affects the body.
IstanbulAges 18–60 - NCT06747611RecruitingPhase 2
Gut bacteria transplant for alopecia areata
This study tests whether transplanting healthy gut bacteria can help people with moderate to severe alopecia areata regrow hair. You will take antibiotics to prepare your gut, then receive the transplant through a colonoscopy or capsules.
Minneapolis, MinnesotaAges 18–75 - NCT05460611Recruiting
1470nm laser treatment for certain types of hair loss
This study tests whether a specific 1470nm laser can improve hair loss in people with certain scalp conditions. It looks for people whose hair loss is stable for several months and who can keep their usual hair treatments unchanged during the study.
Elmsford, New YorkAges 18–99 - NCT07563036Recruiting
JAK2 Protein Changes in Male Pattern Baldness With Minoxidil
This study examines how a protein called JAK2 changes in the scalp when men with male pattern baldness use minoxidil (Rogaine), a common hair-loss treatment. Understanding this might help explain why minoxidil works and improve future treatments.
Cairo, Cairo GovernorateAges 18–50 - NCT07508488RecruitingPhase 2
Deucravacitinib for scarring hair loss (Phase 2)
This study tests an oral medication called deucravacitinib for people with scarring hair loss (frontal fibrosing alopecia or central centrifugal cicatricial alopecia). It aims to see if the drug can reduce inflammation and stop or slow hair loss.
New York, New YorkAges 18 years+ - NCT07107841Recruiting
Hair follicle treatment for pattern baldness
This study tests an experimental treatment using a substance made from your own hair follicles to see if it can help regrow hair in people with pattern baldness. It involves getting several small injections into your scalp over time.
West Hollywood, CaliforniaAges 18–65 - NCT06764329Enrolling by invitationPhase 1/Phase 2
Stem cell therapy for male hair loss
This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.
RawalpindiAges 20–59 - NCT06292533Enrolling by invitation
Ultrapulse for hair loss in Malaysian men and women
This study tests if Ultrapulse treatment helps regrow hair in people with male or female pattern baldness. It may be an option if you haven't used hair loss medications recently or had certain scalp procedures.
Bandar Puchong Jaya, SelangorAges 18 years+ - NCT05723198RecruitingPhase 3
Baricitinib for severe childhood hair loss from alopecia areata
This trial tests whether baricitinib can improve severe alopecia areata (patchy, autoimmune hair loss) in children and teens. It’s meant for people who have had long-lasting, severe hair loss and have tried other treatments without enough benefit.
Birmingham, AlabamaAges 6–17 - NCT05213936Recruiting
Scalp cooling to prevent hair loss during chemotherapy
This trial tests whether cooling the scalp during chemotherapy can help reduce chemotherapy-related hair loss. It focuses on people with curly or kinky hair who are having certain cancer treatments, and it checks safety and how much hair loss happens.
The Bronx, New YorkAges 18 years+ - NCT07242638RecruitingPhase 2
Abrocitinib for skin and hair loss in Down syndrome
This study tests if the pill abrocitinib can help people with Down syndrome who have atopic dermatitis (eczema) or alopecia areata (patchy hair loss). The goal is to see if it improves their skin or hair with manageable side effects.
New York, New YorkAges 12 years+ - NCT07029828RecruitingPhase 3
Long-term study of ritlecitinib for severe alopecia areata in children
This study tests a medicine called ritlecitinib for children with severe alopecia areata (a condition causing hair loss). It is for kids who have already completed a previous study of this medicine to see how well it works and how safe it is over a longer period.
Irvine, CaliforniaAges 6–14 - NCT05177289Recruiting
Light therapy to prevent hair loss during chemotherapy
This study tests whether photobiomodulation (a specific light therapy) can prevent or reduce hair loss caused by chemotherapy. It may help you keep more hair or grow hair back sooner while you’re getting treatment.
Hasselt, LimburgAges 18 years+ - NCT07810504Recruiting
Laser and solution combo for female hair loss
This study tests a combination of a scalp solution and LED light therapy to treat androgenic alopecia (female pattern hair loss). The goal is to see if the two treatments together can help regrow hair and improve scalp health.
Pasadena, CaliforniaAges 35–55 - NCT07803874Recruiting
UV light skin imaging for patchy hair loss
This study uses a special UV light to look at your scalp in a new way. It may help doctors better understand and monitor alopecia areata (a condition that causes patchy hair loss). Participation involves only imaging, no drugs or invasive procedures.
IstanbulAges 18 years+ - NCT07772492RecruitingPhase 3
Study of upadacitinib for teens with severe hair loss
This study tests if upadacitinib can help young people with severe alopecia areata (a condition causing patchy hair loss) regrow their hair. It may be an option if hair loss has been present for less than 8 years and there has been no recent improvement.
Los Angeles, CaliforniaAges 6–17 - NCT07749716RecruitingPhase 2
Oral tablet for severe hair loss
This study tests an experimental oral tablet for severe alopecia areata, a condition that causes patches of hair to fall out. The goal is to see if it can help regrow hair safely. You may be able to join if you have this type of hair loss and meet the health requirements.
Beijing, Beijing MunicipalityAges 18–65 - NCT07733765RecruitingPhase 3
A Study of Ritlecitinib for Moderate Hair Loss from Alopecia Areata
This study tests if the medicine ritlecitinib can help regrow hair in people with alopecia areata, a condition that causes patchy hair loss. It's for young people and adults who have lost between 20% and 50% of their scalp hair for at least 6 months but no more than 10 years.
Encinitas, CaliforniaAges 12 years+ - NCT07693244RecruitingPhase 2
Exosome therapy for male pattern baldness
This trial tests a new treatment using exosomes (tiny particles that help cells communicate) for male pattern baldness. It may help regrow hair or slow further loss.
BeijingAges 18–55 - NCT07618195RecruitingPhase 1/Phase 2
Testing EPI-001 for male and female pattern hair loss
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
Seoul, SeoulAges 19 years+ - NCT07617597RecruitingPhase 3
Testing deuruxolitinib for severe hair loss in Japanese adults
This study tests whether a new drug called deuruxolitinib can help regrow hair in people with alopecia areata (an autoimmune condition causing patchy hair loss). The drug works by blocking certain immune signals that attack hair follicles.
AsahikawaAges 18–65
Hear when a new Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Alopecia trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for alopecia?
- Yes. Clin2 currently lists 82 recruiting alopecia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alopecia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alopecia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.